U.S. REITS Stock News

Event context and recent performance Atlantic Union Bankshares (AUB) has been on investors’ radar after recent share price moves, with the stock showing mixed short term returns and a stronger 1 year total return profile. Over the past week the stock recorded a 3.8% decline, following a 1 day move of around 1.3% lower, while the month performance stands at about 5.9% and the past 3 months show a 3.8% decline. See our latest analysis for Atlantic Union Bankshares. At a share price of $37.40,...

Earlier this month, Neurocrine Biosciences reported new two-year Phase 3 CAHtalyst Adult data showing CRENESSITY enabled sustained reductions in glucocorticoid doses for adults with classic congenital adrenal hyperplasia, with about 70% of patients reaching physiologic dosing and no new safety concerns. The results highlight CRENESSITY’s potential to ease long-term treatment burden by lowering reliance on supraphysiologic steroid doses while maintaining androgen control, a key clinical goal...

American Superconductor recently reported that over the past two years it has delivered very strong annual revenue growth while also reaching positive free cash flow and improving returns on capital, signaling a shift toward financial self-sustainability. This combination of rapid top-line expansion, cash generation, and better capital efficiency suggests that earlier investments in its power resiliency technologies are now translating into tangible operating benefits. Next, we’ll examine...

US Foods Holding (USFD) is back in focus after a series of analyst upgrades tied to its earnings outlook, with attention centering on the role of higher margin private label and value added products. See our latest analysis for US Foods Holding. The recent analyst upgrades come after a strong run, with the share price at $93.20 and a 90 day share price return of 14.68%. The 1 year total shareholder return of 44.77% and 3 year total shareholder return of 142.71% suggest momentum has been...

Commerce Bancshares (CBSH) drew fresh attention after first quarter results showed net interest income of US$299.84 million and net income of US$141.62 million, along with higher net loan charge-offs of US$14.97 million. See our latest analysis for Commerce Bancshares. At a share price of US$50.56, Commerce Bancshares has seen a 4.16% 1 month share price return but a 10.63% decline in 1 year total shareholder return. This suggests recent momentum has not yet reversed the longer term drag. If...

Why DigitalOcean’s recent earnings are drawing fresh attention DigitalOcean Holdings (DOCN) is back on investor radar after reporting Q4 2025 results ahead of expectations, with 18% year-over-year revenue growth and higher non-GAAP EPS supported by rising AI client recurring revenue. See our latest analysis for DigitalOcean Holdings. The share price has rallied strongly over the past year, with a 90 day share price return of 77.6% and a 1 year total shareholder return of 209.63%. This...

PennyMac Financial Services and PennyMac Mortgage Investment Trust recently launched the “Welcome Home: Athlete Mortgage Program,” extending specialized mortgage guidance, exclusive benefits, and educational resources to the wider Team USA athlete community in partnership with the U.S. Olympic & Paralympic Committee. The initiative highlights Pennymac’s effort to cultivate a differentiated client base by tailoring lending support to the unique financial profiles of elite athletes. Next,...

Shoals Technologies Group recently reported quarterly results showing revenue growing 38.6% year on year, ahead of expectations, but paired this with softer full-year EBITDA guidance that pointed to pressure on profitability as the business expands. Management also highlighted growing exposure to battery energy storage systems and solar projects deferred into 2025, which are reshaping the company’s near-term mix of opportunities and risks. An important nuance is that while robust revenue...

Earlier in April 2026, SharkNinja, Inc. broadened its premium lineup by launching new Ninja Luxe Café machines, including a limited-edition David Beckham collaboration, and introducing the Shark PowerDetect Speed Clean & Empty cordless vacuum with advanced detection features and an Auto-Empty Dock priced at US$499. These launches highlight SharkNinja’s push deeper into premium at-home coffee and intelligent cleaning, blending high-end design, personalization, and convenience-focused...

In April 2026, Banner Corporation reported first-quarter 2026 results showing net interest income of US$150.17 million and net income of US$54.72 million, with earnings per share rising year on year and the board approving a 4% increase in the regular quarterly dividend to US$0.52 per share payable May 15, 2026. Alongside stronger earnings, Banner reduced net charge-offs to US$1.22 million and completed a US$47.64 million buyback program, highlighting balance-sheet resilience and active...

Why Churchill Downs (CHDN) Is Back On Investor Radar Churchill Downs (CHDN) has caught fresh attention after a recent share price rebound, with the stock up about 16% over the past month following a weaker year to date patch. See our latest analysis for Churchill Downs. The recent 30 day share price return of 16.46% contrasts with a year to date share price decline of 9.29%, while the 1 year total shareholder return of 15.39% sits against a 3 year total shareholder return decline of 29.87%...

Earlier this month, Costco Wholesale Corporation’s board of directors approved a quarterly cash dividend increase from US$1.30 to US$1.47 per share (US$5.88 annualized), payable on May 15, 2026, to shareholders of record as of May 1, 2026. This dividend hike, coming alongside continued strong sales and high membership renewal rates, underlines Costco’s emphasis on recurring member income and disciplined cash returns. Now we’ll examine how Costco’s higher quarterly dividend shapes the...

There's been a notable change in appetite for Calix, Inc. ( NYSE:CALX ) shares in the week since its quarterly report...

Antero Midstream Corporation ( NYSE:AM ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Travere Therapeutics (TVTX) just secured full FDA approval for FILSPARI in focal segmental glomerulosclerosis without nephrotic syndrome, extending its use beyond IgA nephropathy and reshaping how investors may think about the company’s rare kidney portfolio. See our latest analysis for Travere Therapeutics. The FDA decision arrives alongside a sharp 46.95% 1 month share price return and a 37.57% 3 month share price return, while the 1 year total shareholder return of 120.95% points to strong...

Edgewise Therapeutics (EWTX) has drawn investor attention after recent trading left the stock around $31.58, with returns showing mixed short term moves but a strong year to date and 1 year profile. See our latest analysis for Edgewise Therapeutics. Recent trading has been choppy, with a 1 day share price return of 1.12% and a 7 day share price return of an 8.28% decline. However, momentum over the past 90 days and year to date remains positive, supported by a 1 year total shareholder return...

Atomera Incorporated recently announced it has expanded its long-running collaboration with Synopsys to develop gallium nitride (GaN) device modeling workflows for radio frequency and power semiconductor applications using Synopsys’ Sentaurus TCAD and Atomera’s MSTcad toolset. This move extends Atomera’s MST modeling capabilities into GaN, potentially deepening its role in high-value RF and power markets by integrating more tightly into Synopsys’ widely used design ecosystem. We’ll now...

Evolv Technologies Holdings, Inc. recently announced multi-year subscription agreements and marketing partnerships with the University of Washington’s athletic department and Crypto.com Arena, expanding deployments of its Evolv Express Gen2 and eXpedite AI-based screening systems across major college and professional sports venues. These high-traffic stadium and arena wins highlight growing adoption of Evolv’s subscription-based security platforms in sports and entertainment, reinforcing its...

The American Academy of Dermatology’s new pediatric guidelines give a strong, evidence-backed endorsement to Arcutis Biotherapeutics (ARQT) lead product ZORYVE for children with mild to moderate atopic dermatitis, highlighting efficacy, safety, and long-term use. See our latest analysis for Arcutis Biotherapeutics. At a share price of $23.26, Arcutis has a 1 day share price return of 1.75%, while the year to date share price return of 19.79% decline contrasts with a 1 year total shareholder...

Event context and recent share performance Innospec (IOSP) shares recently closed at US$77.15, with the stock showing a return of about 0.6% over the past day and 1.3% over the past week. This sets the context for its latest trading moves. See our latest analysis for Innospec. Recent trading has been mixed, with a 6.6% 1 month share price return contrasting with a 4.6% 3 month share price decline and a 12.2% 1 year total shareholder return loss. This suggests momentum has cooled after a short...

Recent performance and context for W.W. Grainger W.W. Grainger (GWW) has drawn fresh investor attention after recent share price moves, with the stock showing mixed short term returns but positive performance over the month and the past 3 months. See our latest analysis for W.W. Grainger. Recent trading has been slightly softer, with a 1-day share price return of 1.45% and a 7-day share price return of 1.29%. That sits against a 30-day share price return of 6.7% and a 1-year total shareholder...

Some investors may be wondering whether Broadcom's share price still reflects good value after a strong run, or if expectations are getting ahead of themselves. Broadcom's stock has returned 4.0% over the past week, 32.6% over the last 30 days, 21.6% year to date, 121.6% over the past year and a very large return over 5 years. These moves have kept Broadcom in the spotlight, as investors weigh what the current price indicates about future prospects and risk. Recent coverage has focused on...

Recent performance snapshot for Microsoft (MSFT) With no single headline event driving attention today, Microsoft (MSFT) is drawing interest as investors reassess its recent share performance, business mix, and current valuation signals across its major cloud, productivity, and personal computing segments. See our latest analysis for Microsoft. At a latest share price of $424.62, Microsoft has recently seen a 16.0% 1 month share price return. Its 90 day share price return of 8.9% and year to...